Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity

Journal of Medical Virology

Volumn 59, Issue 3, 1999, Pages 329-334

  Green, Sharone ^a   Vaughn, David W ^b,e   Kalayanarooj, Siripen ^c   Nimmannitya, Suchitra ^c   Suntayakorn, Saroj ^d   Nisalak, Ananda ^b   Rothman, Alan L ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c Queen Sirikit National Institute for Child Health   (Thailand)

^d Kamphaeng Phet Provincial Hospital   (Thailand)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; PLEURA EFFUSION; SEROTYPE;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHILD; DENGUE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12;

DENGUE VIRUS;

EID: 0032852558     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G     Document Type: Article

References (37)

1. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte HJ. 1997. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol 27:2994-3000.
2. Bethell DB, Flobbe K, Phuong CXT, Day NPJ, Phuong PT, Buurman WA, Cardosa MJ, White NJ, Kwiatkowski D. 1998. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 177:778-782.
3. Burke DS, Nisalak A, Johnson DE, Scott RM. 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.
4. Chehimi J, Paganin C, Frank I, Chouaib S, Starr S, Trinchieri G. 1995. Interleukin-12 in the pathogenesis and therapy of HIV disease. Res Immunol 146:605-614.
5. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinnarello CA. 1995. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492-5499.
6. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
7. + cytotoxic T-lymphocyte clones. J Virol 73:3623-3629.
8. Gerard C, Bruyns C, Marchant A, Abramawicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550.
9. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25:200-206.
10. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179:755-762.
11. Griffin DE, Ward BJ, Esolen LM. 1994. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 170:S24-31.
12. + T cells. J Immunol 160:3188-3193.
13. Halstead SB, O'Rourke EJ. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
14. Hober D, Poli L, Roblin B, Gestes P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattre P, Maniez-Montreuil M. 1993. Serum levels of tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), and interleukin-1-β (IL-1β) in dengue-infected patients, Am J Trop Med Hyg 48:324-331.
15. Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattre P. 1996. High levels of sTNFR p75 and TNFα in dengue-infected patients. Microbiol Immunol. 40:569-573.
16. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, Viramitrachai W, Ratanachu-eke S, Kiatpolpoj S, Innis BL, Rothman AL, Nisalak A, Ennis FA. 1997. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 176:313-321.
17. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. 1996. Mechanism of immunosuppression of cell-mediated immunity by measles virus. Science 273:228-231.
18. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA. 1991. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-γ in sera of children with dengue. J Clin Invest 88:1473-1480.
19. Kurane I, Meager A, Ennis FA. 1989. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon γ production, and cytotoxic activity. J Exp Med 170:763-775.
20. Kurane I, Rothman AL, Bukowski JF, Kontny U, Janus J, Innis BL, Nisalak A, Nimmannitya S, Meager A, Ennis FA. 1990. T-lymphocyte responses to dengue viruses. In: MA Brinton, FX Heinz, editors. New aspects of positive-strand RNA viruses. Washington, DC: American Society for Microbiology, p 301-304.
21. Lehmann AK, Halstensen A, Sornes S, Rokke O, Waage A. 1995. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 63:2109-2112.
22. Ma X, D'Andrea A, Kubin M, Aste-Amezaga M, Sartori A, Monteiro J, Showe L, Wysocka M, Trinchieri G. 1995. Production of IL-12. Res Immunol 146:432-438.
23. + cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 98:1684-1692.
24. Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL. 1999. Impaired T cell proliferation in acute dengue infection. J Immunol 162:5609-5615.
25. Monath TP. 1994. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA 91:2395-2400.
26. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. 1993. Interleukin-10. Annu Rev Immunol 11:165-190.
27. Nimmannitya S. 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 18:392-397.
28. O'Garra A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275-283.
29. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890-1893.
30. Sabin AB. 1952. Research on dengue during World War II. Am J Trop Med Hyg 1:30-50.
31. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120:653-669.
32. Trinchieri G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008-4027.
33. Trinchieri G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276.
34. van der Poll T, Jansen PM, Montegut WJ, Braxton CC, Calvano SE, Stackpole SA, Smith SR, Swanson SW, Hack CE, Lowry SF, Moldawer LL. 1997. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 158: 1971-1975.
35. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A. 1997. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 176:322-330.
36. Wenisch C, Parschalk B, Narzt E, Looareesuwan S, Graninger W. 1995. Elevated serum levels of IL-10 and IFNγ in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 74:115-117.
37. World Health Organization. 1986. Dengue haemorrhagic fever: diagnosis, treatment and control. Geneva: WHO. p 1-60.